SARTORIUS STED BIO And 5 Other Stocks Have Very High Payout Ratio

(VIANEWS) – BEWI (BEWI.OL), AMSC (AMSC.OL), ERAMET (ERA.PA) are the highest payout ratio stocks on this list.

We have congregated information about stocks with the highest payout ratio up until now. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. BEWI (BEWI.OL)

6826.06% Payout Ratio

BEWi ASA provides packaging components and insulation solutions internationally. The company operates through RAW, Packaging & Components (P&C), Insulation & Construction (I&C), and Circular segments. The RAW segment produces raw materials, including white and grey expanded polystyrene, general purpose polystyrene, and BioFoam made from organic materials. The P&C segment manufactures and sells standard and customised solutions for various industrial sectors, including boxes for transportation of fish and other foods, protective packaging for fine goods, and technical and automotive components. The I&C segment manufactures a range of solutions for insulation and infrastructure, as well as systems for the building and construction industry. The Circular segment collects and recycles used material, including initiatives to raise knowledge and awareness about recycling and waste management. The company sells its products to food, pharmaceutical, automotive, hobby and leisure, residential housing, and thermal insulation industries. The company was founded in 1980 and is headquartered in Trondheim, Norway. BEWi ASA is a subsidiary of BEWI Invest AS.

Earnings Per Share

As for profitability, BEWI has a trailing twelve months EPS of kr-1.28.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.23%.

Yearly Top and Bottom Value

BEWI’s stock is valued at kr32.65 at 22:10 EST, below its 52-week low of kr35.30.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Nov 10, 2022, the estimated forward annual dividend rate is 1.1 and the estimated forward annual dividend yield is 3.03%.

More news about BEWI.

2. AMSC (AMSC.OL)

252.69% Payout Ratio

AMSC ASA, through its subsidiaries, operates as a ship owning and lease finance company in the United States. The company purchases and bareboat charters out vessels to operators and end users. It operates a fleet of nine product tankers, one shuttle tanker, and one subsea construction vessel. The company was formerly known as American Shipping Company ASA and changed its name to AMSC ASA in October 2022. AMSC ASA was founded in 2005 and is headquartered in Lysaker, Norway.

Earnings Per Share

As for profitability, AMSC has a trailing twelve months EPS of kr-1.72.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.

Moving Average

AMSC’s value is way under its 50-day moving average of kr39.16 and way below its 200-day moving average of kr41.54.

More news about AMSC.

3. ERAMET (ERA.PA)

97.73% Payout Ratio

ERAMET S.A. operates as a mining and metallurgical company in France, Asia, Europe, North America, and internationally. The company extracts and processes manganese ore and nickel ore; and extracts and develops mineral sands. It also produces ferronickel, nickel pig iron, briquettes, nickel salts, high purity nickel, nickel ferroalloys, and alloy steel and casting; manganese alloys, such as high-carbon ferromanganese, silicomanganese, low and medium-carbon ferromanganese, and low-carbon silicomanganese for use in batteries, pigments, construction, and automotive industries; and mineral sands, such as titanium dioxide, high-purity pig iron, zircon, and ilmenite used in ceramics and pigments. In addition, it operates Moanda mine in Gabon; nickel mines in New Caledonia and Indonesia; and mineral sand mine in Senegal and Argentina. ERAMET S.A. was incorporated in 1880 and is headquartered in Paris, France.

Earnings Per Share

As for profitability, ERAMET has a trailing twelve months EPS of €3.58.

PE Ratio

ERAMET has a trailing twelve months price to earnings ratio of 19.68. Meaning, the purchaser of the share is investing €19.68 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.57%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 26, 2023, the estimated forward annual dividend rate is 3.5 and the estimated forward annual dividend yield is 4.94%.

Yearly Top and Bottom Value

ERAMET’s stock is valued at €70.45 at 22:10 EST, way below its 52-week high of €103.20 and way above its 52-week low of €57.85.

Moving Average

ERAMET’s worth is above its 50-day moving average of €64.10 and below its 200-day moving average of €70.99.

More news about ERAMET.

4. ODFJELL SER. A (ODF.OL)

47.92% Payout Ratio

Odfjell SE provides services for the transportation and storage of bulk liquid chemicals, acids, edible oils, and other specialty products in North America, South America, Norway, the Netherlands, rest of Europe, the Middle East, Asia, Africa, and Australasia. The company operates through Chemical Tankers and Tank Terminals segments. It owns and operates chemical tankers that offer global and regional transportation; and tank terminals, which provide storage of various chemical and petroleum products. As of December 31, 2023, it operated a chemical tanker fleet of 68 vessels, including 46 owned/leased, 5 operational bareboat, 14 time chartered, and 3 pool vessels. The company's terminal network consists of 459 tanks with 1.3 million cubic meters of storage capacity. Odfjell SE was incorporated in 1914 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, ODFJELL SER. A has a trailing twelve months EPS of kr27.55.

PE Ratio

ODFJELL SER. A has a trailing twelve months price to earnings ratio of 4.97. Meaning, the purchaser of the share is investing kr4.97 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.2%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 21.1% and 1061.2%, respectively.

Moving Average

ODFJELL SER. A’s worth is higher than its 50-day moving average of kr135.37 and way above its 200-day moving average of kr110.77.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Feb 13, 2024, the estimated forward annual dividend rate is 13.25 and the estimated forward annual dividend yield is 10.04%.

More news about ODFJELL SER. A.

5. SARTORIUS STED BIO (DIM.PA)

42.86% Payout Ratio

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Earnings Per Share

As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.36.

PE Ratio

SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 78.66. Meaning, the purchaser of the share is investing €78.66 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.03%.

Moving Average

SARTORIUS STED BIO’s worth is above its 50-day moving average of €249.71 and way above its 200-day moving average of €233.94.

Volume

Today’s last reported volume for SARTORIUS STED BIO is 48852 which is 29.49% below its average volume of 69287.

More news about SARTORIUS STED BIO.

6. EQUASENS (EQS.PA)

35.98% Payout Ratio

Equasens Société anonyme provides healthcare IT solutions in Europe. It offers id. PATIENT, a business software; id. MOBILITY, a back-office management software; pandaLAB Pro, an instant messaging solution; Id. VENTE, an HAS-certified drug database; Id. COMMANDE, an order management module; dispensing robots; Services Ségur id; id. DOSAGE, a dosage management and printing module; multimeds reconditioning robot; compliance monitoring module; home delivery module; home equipment rental management module; Visiodroits module; and Website connector. The company also provides id. DESK, an informative and interactive dashboard; id. UP!, a real-time monitoring and control application of id management software; id. EASYQ, a queue management solution; Miaterapia; Id. SHOW, an application for managing real-time communications on pharmacy screens; Pharmaweb; TsGatePro; LMO, a dispensary business software; and LGO, a dispensary management software. In addition, it offers DOMILINK HAD software; mobiSOINS mobility tool; MEMORialis, support software for alzheimer's monitoring teams; HOSPILINK, an hospital information system applications; HOSPILINK DPI, a computerized patient file; HOSPILINK LOOKUP Big Data; eNephro solutions; NOVIAcare solutions; KAP&LINK2, a contact chip card reader terminal and NFC reader; eS-KAP-Ad, a connected nomadic tool incorporating software; KAP-INSIDE, a mobile terminal; and TI-KAP allowing access to contact and contactless cards. Further, the company provides AUTHENTICATOR, a patented authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; ExpressVitale; MédiStory, that automates the transfer of invoicing to the healthcare professional's accounting. Additionally, it offers medical telesecretarial services for healthcare professionals, as well as equipment lease financing solutions. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.

Earnings Per Share

As for profitability, EQUASENS has a trailing twelve months EPS of €3.2.

PE Ratio

EQUASENS has a trailing twelve months price to earnings ratio of 16.03. Meaning, the purchaser of the share is investing €16.03 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.25%.

More news about EQUASENS.

1. 1 (1)

1% Payout Ratio

1

Earnings Per Share

As for profitability, 1 has a trailing twelve months EPS of €1.

PE Ratio

1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).

Earnings Before Interest, Taxes, Depreciation, and Amortization

1’s EBITDA is 1.

Volume

Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.

More news about 1.

Leave a Reply

Your email address will not be published. Required fields are marked *